High-risk stage two cancer patients could be identified more easily and accurately, due to a hopeful new prognostic method developed by researchers at the University of St Andrews.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.